Healing & Recovery Research Peptides South Africa

BPC-157 Research: What the Studies Show

In animals, BPC-157 works like a powerhouse to rebuild tissue and cut down inflammation. In humans, early small-scale usage looks promising and safe, but we still lack the golden-standard trial data to officially prove it works or map out long-term side effects. There are no large-scale, peer-reviewed Phase I–III randomized clinical trials published for BPC-157 in major medical journals. While it is heavily studied and shows massive success in animals, human evidence is limited to small pilot studies, retrospective charts, and a recently initiated clinical trial.

TB-500 Research: What the Studies Show

A study-by-study look at the TB-500 and Thymosin Beta-4 literature — the dermal wound-healing work, the phase 1 human safety trial, how the fragment is metabolised, and where the evidence runs out.

VIP Peptide Research: Trials, Mechanisms & What the Studies Show

Vasoactive Intestinal Peptide (VIP) is a 28-amino-acid endogenous neuropeptide researched for its potent anti-inflammatory, vasodilatory and immunomodulatory properties. The literature spans respiratory failure, autoimmune disease, gut immunity and neuroimmunology.

Thymosin Alpha-1 Research: Trials, Immune Data & What the Studies Show

Thymosin Alpha-1 (Tα1) is a 28-amino-acid thymus peptide. As the thymus shrinks with age, native Tα1 falls, which is why it is studied in immune-aging research. The synthetic medicine form is thymalfasin (Zadaxin). It is licensed in many countries for chronic hepatitis B and related immune-support uses. This listing is not Zadaxin and is for laboratory research only.

KPV Research: Preclinical Studies, Mechanisms & What the Data Show

KPV (Lysine-Proline-Valine) is a naturally derived tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) with potent anti-inflammatory and antimicrobial activity in laboratory models. Note the evidence ceiling clearly: there are zero completed human clinical trials for KPV. Everything below is extrapolated from in vitro (cell culture) and in vivo (animal model) work.

LL-37 Research: Trials, Data & What the Studies Show

LL-37 is the only cathelicidin antimicrobial peptide made by the human body. The published work is largely animal-tissue and human cell-culture data. It shows powerful antimicrobial and wound-healing findings alongside well-documented autoimmune and tumour-growth signals that researchers also track.

Thymalin Research: Human Trials, Gene Expression Data & What the Studies Show

Modern research-grade Thymalin is a synthetic peptide complex that mirrors the short polypeptide fractions originally characterised at the Khavinson Institute of Bioregulation and Gerontology in St. Petersburg. The published literature covers in-vitro stem cell assays, epigenetic gene expression mapping, animal tumour studies and decades of human clinical tracking.